Ifp Advisors, Inc Novavax Inc Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Novavax Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 4,675 shares of NVAX stock, worth $35,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,675

Previous 3,996 16.99%

Holding current value

$35,109

Previous $25,000 16.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$5.43 - $7.74 $3,686 - $5,255	679 Added 16.99%	4,675 $29,000
Q1 2025 May 05, 2025	BUY	$6.41 - $10.82 $2,243 - $3,787	350 Added 9.6%	3,996 $25,000
Q4 2024 Feb 04, 2025	BUY	$7.22 - $14.68 $1,451 - $2,950	201 Added 5.83%	3,646 $29,000
Q2 2024 Jul 30, 2024	BUY	$3.89 - $20.97 $1,556 - $8,388	400 Added 13.14%	3,445 $43,000
Q3 2023 Oct 12, 2023	BUY	$6.81 - $9.74 $3,098 - $4,431	455 Added 17.57%	3,045 $22,000
Q2 2023 Aug 04, 2023	BUY	$6.67 - $9.52 $3,028 - $4,322	454 Added 21.25%	2,590 $19,000
Q1 2023 Apr 18, 2023	SELL	$5.76 - $12.48 $27,982 - $60,627	-4,858 Reduced 69.46%	2,136 $14,000
Q4 2022 Feb 07, 2023	BUY	$8.86 - $25.04 $47,498 - $134,239	5,361 Added 328.29%	6,994 $52,000
Q3 2022 Nov 08, 2022	BUY	$18.2 - $76.12 $24,169 - $101,087	1,328 Added 435.41%	1,633 $20,000
Q2 2022 Sep 06, 2022	BUY	$36.28 - $75.29 $11,065 - $22,963	305 New	305 $9,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $11,065 - $22,963	-305 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$69.73 - $142.9 $6,903 - $14,147	99 Added 48.06%	305 $22,000
Q1 2022 Aug 08, 2022	BUY	$69.73 - $142.9 $836 - $1,714	12 Added 6.19%	206 $15,000
Q4 2021 Jan 12, 2022	SELL	$134.56 - $217.97 $6,997 - $11,334	-52 Reduced 21.14%	194 $27,000
Q3 2021 Oct 06, 2021	SELL	$177.8 - $270.58 $13,157 - $20,022	-74 Reduced 23.13%	246 $52,000
Q2 2021 Jul 13, 2021	BUY	$121.0 - $257.67 $3,388 - $7,214	28 Added 9.59%	320 $69,000
Q1 2021 Apr 30, 2021	SELL	$112.98 - $319.93 $4,971 - $14,076	-44 Reduced 13.1%	292 $54,000
Q4 2020 Jan 25, 2021	BUY	$78.74 - $139.5 $7,480 - $13,252	95 Added 39.42%	336 $36,000
Q3 2020 Oct 29, 2020	BUY	$79.44 - $178.51 $19,145 - $43,020	241 New	241 $26,000
Q2 2020 Aug 05, 2020	SELL	$13.86 - $83.61 $180 - $1,086	-13 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$3.93 - $16.0 $51 - $208	13 New	13 $0

Others Institutions Holding NVAX

# of Institutions

306

Shares Held

94.9M

Call Options Held

6.11M

Put Options Held

10.7M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $587M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account